Disclosure Of Fair Value Measurement [Text Block]

Egetis Therapeutics - Filing #5995613

Concept As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
Disclosure of fair value measurement [text block]
Disclosure of fair value measurement of assets [text block]
Disclosure of fair value measurement of assets [abstract]
Disclosure of fair value measurement of assets [line items]
Assets
7,923,000,000 SEK
7,602,000,000 SEK
Reconciliation of changes in fair value measurement, assets [abstract]
Disclosure of fair value measurement of equity [text block]
Disclosure of fair value measurement of equity [abstract]
Disclosure of fair value measurement of equity [line items]
Equity
1 610,1 SEK
2 057,7 SEK
248,000,000 SEK
4,929,000,000 SEK
204,000,000 SEK
154,000,000 SEK
1 266,5 SEK
1 780,0 SEK
5,456,000,000 SEK
167,000,000 SEK
5,062,000,000 SEK
9,396,000,000 SEK
113,000,000 SEK
61,000,000 SEK
1 428,4 SEK
Reconciliation of changes in fair value measurement, entity's own equity instruments [abstract]

Talk to a Data Expert

Have a question? We'll get back to you promptly.